Page last updated: 2024-08-21

boldine and Bone Loss, Osteoclastic

boldine has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cafferata, EA; Carvajal, P; Cassels, BK; Castro-Saavedra, S; Cortés, BI; Cortez, C; Fuentes-Barros, G; Hernández, M; Melgar-Rodríguez, S; Rivera, F; Vernal, R1
Guo, B; Ju, D; Liu, M; Lu, C; Qiao, S; Tan, Y; Wang, G; Xiao, C; Xu, H; Zhao, H1

Other Studies

2 other study(ies) available for boldine and Bone Loss, Osteoclastic

ArticleYear
Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance.
    Journal of periodontology, 2021, Volume: 92, Issue:1

    Topics: Alveolar Bone Loss; Animals; Aporphines; Bone Resorption; Mice; Osteoclasts; Osteoprotegerin; Periodontitis; RANK Ligand; T-Lymphocytes, Regulatory; X-Ray Microtomography

2021
Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
    International immunopharmacology, 2017, Volume: 51

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aporphines; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cells, Cultured; Disease Models, Animal; Humans; Litsea; Male; Mice; Mice, Inbred C57BL; Osteogenesis; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction

2017